Systematic validation of predicted microRNAs for cyclin D1

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally.
• A single miRNA can target hundreds of genes, and a single gene can be targeted by multiple miRNAs.
• Experimental validation of predicted miRNA/mRNA interactions is limited, especially using reporter systems.

Purpose of the Study:

• To experimentally validate microRNAs targeting the proto-oncogene cyclin D1 (CCND1) using a luciferase reporter assay.
• To identify novel microRNAs that regulate CCND1 expression.
• To investigate the functional role of validated microRNAs in cancer-related processes.

Main Methods:

• Utilized luciferase reporter assays to test the regulatory effects of 51 predicted microRNA precursors on the 3'-untranslated region (UTR) of the CCND1 gene.
• Employed miRanda as the primary prediction tool for identifying potential miRNA targets.
• Confirmed microRNA expression using real-time PCR and assessed CCND1 regulation at mRNA and protein levels.

Main Results:

• 45 out of 51 cloned microRNA precursors expressed detectable levels of exogenous miRNAs.
• Seven microRNAs were identified as suppressors of luciferase activity linked to the CCND1 3'-UTR, with a 35% reduction cutoff.
• Three novel microRNAs were validated as CCND1 regulators, and miR-503 demonstrated suppression of both CCND1 mRNA and protein, reduced cell proliferation, and inhibited cell growth, suggesting a tumor suppressor role.

Conclusions:

• Provides a more comprehensive understanding of microRNA interactions with CCND1.
• Highlights the critical importance of experimental validation for miRNA target interactions.
• Suggests miR-503 as a potential therapeutic target for cancer treatment.